MARAVAI LIFE SCIENCES
Maravai LifeSciences was formed in March 2014 as a partnership among Carl Hull and Eric Tardif -- proven leaders in the life sciences industry -- and GTCR, a leading private equity firm. Maravai’s mission is to build a transformative life sciences products company by acquiring outstanding businesses and accelerating their growth. They do this through direct cash investments in their existing operations, by acquiring complementary businesses or product lines and by contributing our proven operating expertise.
MARAVAI LIFE SCIENCES
Social Links:
Industry:
Biotechnology Health Care
Founded:
2014-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.maravai.com
Total Employee:
51+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
1000 M USD
Technology used in webpage:
Viewport Meta SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager Content Delivery Network Global Site Tag Microsoft Exchange Online
Similar Organizations
1859
1859 is a biotechnology company focusing on the discovery and development of next-generation therapeutics.
Ansun BioPharma
Ansun BioPharma is a clinical-stage biopharmaceutical company focused on the development of host-directed anti-viral.
Gelesis
Gelesis is a biotechnology company developing first-in-class therapeutics to safely treat obese, overweight, and diabetic patients.
Homology Medicines
Homology Medicines is a genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases.
Medicago
Medicago is a biotechnology company focused on the research, development, production, and commercialization of vaccines in Canada.
Ribon Therapeutics
Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.
Tandem Diabetes Care
Tandem diabetes care provides products that empower both people with diabetes and those who care for them.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-01-28 | MyChem | MyChem acquired by Maravai Life Sciences | 240 M USD |
| 2018-01-03 | Glen Research Corp. | Glen Research Corp. acquired by Maravai Life Sciences | N/A |
| 2016-10-26 | TriLink BioTechnologies | TriLink BioTechnologies acquired by Maravai Life Sciences | N/A |
| 2016-10-26 | Cygnus Technologies | Cygnus Technologies acquired by Maravai Life Sciences | N/A |
Investors List
GTCR
GTCR investment in Private Equity Round - Maravai Life Sciences
Key Employee Changes
| Date | New article |
|---|---|
| 2020-02-11 | Maravai LifeSciences Hires Two Senior Executives for TriLink BioTechnologies |
Official Site Inspections
http://www.maravai.com Semrush global rank: 2.99 M Semrush visits lastest month: 5.43 K
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Maravai Life Sciences"
Who we are - Maravai LifeSciences
Mar 18, 2025 Maravai LifeSciences is helping biotech, biopharma and life sciences companies everywhere deliver novel vaccines, therapeutics and diagnostics. Maravai makes all phases of …See details»
Company information - Maravai LifeSciences Holdings, Inc.
Maravai's portfolio companies are ISO-9001:2015 certified and have earned hundreds of thousands of citations in peer-reviewed scientific publications. Contact information. Company …See details»
Maravai LifeSciences Holdings, Inc. (MRVI)
Jan 28, 2025 Maravai LifeSciences is a leading life sciences company providing critical products to enable the development of novel vaccines, drug therapies, and diagnostics, and to support …See details»
Maravai Life Sciences - Crunchbase Company Profile & Funding
Maravai LifeSciences was formed in March 2014 as a partnership among Carl Hull and Eric Tardif -- proven leaders in the life sciences industry -- and GTCR, a leading private equity firm. …See details»
Maravai Foundation - Maravai LifeSciences
The Maravai LifeSciences Foundation seeks out opportunities to contribute to the improvement of human health. Our giving supports charitable, scientific, and educational endeavors, with …See details»
Leadership :: Maravai LifeSciences Holdings, Inc. (MRVI)
Before joining Maravai, in October of 2022, she was the Vice President and General Manager, Advanced Therapies, at Thermo Fisher Scientific, where she oversaw CDMO services for …See details»
Maravai: A Cornerstone in mRNA and Biologics Innovation
Dec 20, 2024 Following this deal, Maravai took a hiatus in acquisitions. As the biotech “bubble” started forming following the pandemic, Maravai raised $1.86 Billion from its IPO and became …See details»
Our impact - Maravai LifeSciences
Maravai supports initiatives designed to spark an interest among K-12 students in both STEM and STEAM. We believe it’s incumbent upon us to develop students’ interests and skills in these …See details»
Maravai LifeSciences - Overview, News & Similar companies
May 9, 2024 Maravai LifeSciences To Host Earnings Conference Call on Wednesday, August 7, 2024 SAN DIEGO, July 10, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. …See details»
Financial results - Maravai LifeSciences Holdings, Inc. (MRVI)
Dec 31, 2024 Maravai LifeSciences and its brands are the proven catalysts for helping deliver novel vaccines, therapeutics and diagnostics with biotech, biopharma and life sciences …See details»
Maravai LifeSciences: Upside Not Likely In 2025, But Company Can ...
2 days ago Maravai LifeSciences Holdings, Inc.'s stock has plummeted from $60 to $2.1 per share due to declining COVID vaccine-related revenues, but I am upgrading from a "Sell" to a …See details»
Maravai Lifesciences Reports Fourth Quarter and Full Year 2024 ...
Mar 18, 2025 Schedules Conference Call for Thursday, March 20, 2025SAN DIEGO, March 18, 2025 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: …See details»
MRVI Investors Reminded of Opportunity to Lead Maravai …
3 days ago LOS ANGELES, April 3, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Maravai …See details»
Supply chain - Maravai LifeSciences
Maravai establishes partnerships with qualified suppliers who embrace our commitment to diversity, equity and inclusion. One of our procurement priorities is to partner with diverse and …See details»
Maravai LifeSciences Plans to Acquire DNA and RNA ... - Business …
Nov 7, 2024 Maravai is a leading life sciences company providing critical products to enable the development of drug therapies, diagnostics and novel vaccines and to support research on …See details»
Faruqi & Faruqi Reminds Maravai LifeSciences Investors of
23 hours ago Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Maravai...See details»
Maravai LifeSciences Plans to Acquire DNA and RNA Business of …
Nov 7, 2024 “Officinae Bio’s unique approach to sequence design brings a cutting-edge advantage to our Nucleic Acid Production business,” said Trey Martin, CEO of Maravai …See details»
Levi & Korsinsky Notifies Shareholders of Maravai LifeSciences …
6 days ago NEW YORK, April 1, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Maravai LifeSciences Holdings, Inc. ("Maravai LifeSciences" or the "Company") (NASDAQ: …See details»
Operations - Maravai LifeSciences
Safety is the cornerstone of every Maravai miracle. The safety of our people is always the top priority, and we strive to create a work environment that prevents illness and injuries and …See details»
Maravai LifeSciences Acquires Assets and Intellectual Property …
Jan 28, 2025 Maravai is a leading life sciences company providing critical products to enable the development of drug therapies, diagnostics and novel vaccines and to support research on …See details»